Hepatocellular carcinoma (HCC) is the most common primary liver cancer and is the fifth
leading cause of cancer death worldwide and the third leading cause of all diseases …

Background Hepatocellular carcinoma (HCC) typically recurs following primary treatment.
The primary objective of this systematic review was to evaluate the safety and efficacy of …

Background The efficacy of repeat hepatic resection (rHR) in the treatment of recurrent
hepatocellular carcinoma compared with radiofrequency or microwave ablation after …

Background: Orthotopic liver transplantation (OLT) for patients with small hepatocellular
carcinoma (HCC) is widely accepted, and the usefulness of local ablation techniques as a …

Aim Local recurrence of hepatocellular carcinoma (HCC) after local ablation therapy (LAT) is
a serious problem; however, the optimal treatment strategy remains unclear. Methods A …

Percutaneous treatment of hepatocellular carcinoma (HCC) encompasses a vast range of
techniques, including monopolar radiofrequency ablation (RFA), multibipolar RFA …

Background Percutaneous ablative therapies (PAT) are valuable modalities for
posthepatectomy recurrent hepatocellular carcinoma (RHCC), but its impact on long-term …

The management of hepatocellular carcinoma (HCC) remains complex and will continue to
rely on the multidisciplinary input of hepatologists, surgeons, radiologists, oncologists and …

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and
is most commonly found in the setting of liver cirrhosis. Treatment of HCC must consider …

Local ablation therapy is one of the best curative treatment options for hepatocellular
carcinoma, and can be an alternative to resection. Generally, attempting local complete cure …